Fecal Immunochemical Testing (FIT) is a central tool in colorectal cancer (CRC) screening. To improve the selection of individuals for colonoscopy, risk models combining FIT with additional CRC risk f
RATIONALE: Use of a web-based risk assessment tool may help improve screening rates for colorectal cancer. PURPOSE: This randomized clinical trial is studying personal electronic health records to see
Study hypothesis: Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands is feasible. Please note that the follow-up study to this randomised controlled
Expected detection rate and associated NNS to detect 1 case of any advanced neoplasm and cancer at screening colonoscopy at age 55 after annual FIT testing from age 50 to age 54, compared to no preced
The American Cancer Society and The Centers for Disease Control and Prevention in collaboration with The National Colorectal Cancer Roundtable published "How to Increase Colorectal Cancer Screening ra
